View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Dashboards
  2. Patents
May 30, 2022

Robotics: innovation in clinical trials drops in Q1 2022

Analysis of patent filings shows a shrinking level of robotics related applications in the industry over the past year

By Data Journalism Team

Research and innovation in robotics in the clinical trial operations sector has declined in the last year.

The most recent figures show that the number of robotics related patent applications in the industry stood at 22 in the three months ending March – down from 42 over the same period in 2021.

Figures for patent grants related to robotics followed a similar pattern to filings – shrinking from 19 in the three months ending March 2021 to nine in the same period in 2022.

The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.

Robotics is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.

The figures also provide an insight into the largest innovators in the sector.

Johnson & Johnson was the top robotics innovator in the clinical trial operations sector in the latest quarter. The company, which has its headquarters in the United States, filed seven robotics related patents in the three months ending March. That was down from 20 over the same period in 2021.

It was followed by the Switzerland based F. Hoffmann-La Roche Ltd with seven robotics patent applications, the United States based Thermo Fisher Scientific Inc (6 applications), and Germany based Bayer AG (2 applications).

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena